These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 19592687)

  • 1. Probiotic carbohydrates reduce intestinal permeability and inflammation in metabolic diseases.
    Strowski MZ; Wiedenmann B
    Gut; 2009 Aug; 58(8):1044-5. PubMed ID: 19592687
    [No Abstract]   [Full Text] [Related]  

  • 2. Role of gut microflora in the development of obesity and insulin resistance following high-fat diet feeding.
    Cani PD; Delzenne NM; Amar J; Burcelin R
    Pathol Biol (Paris); 2008 Jul; 56(5):305-9. PubMed ID: 18178333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The intricate association between gut microbiota and development of type 1, type 2 and type 3 diabetes.
    Bekkering P; Jafri I; van Overveld FJ; Rijkers GT
    Expert Rev Clin Immunol; 2013 Nov; 9(11):1031-41. PubMed ID: 24138599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Gut Microbiota on Obesity, Diabetes, and Cardiovascular Disease Risk.
    Miele L; Giorgio V; Alberelli MA; De Candia E; Gasbarrini A; Grieco A
    Curr Cardiol Rep; 2015 Dec; 17(12):120. PubMed ID: 26497040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Could the beneficial effects of dietary calcium on obesity and diabetes control be mediated by changes in intestinal microbiota and integrity?
    Gomes JM; Costa JA; Alfenas RC
    Br J Nutr; 2015 Dec; 114(11):1756-65. PubMed ID: 26400630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of probiotics on bile acids in diseases and aging.
    Sivamaruthi BS; Fern LA; Rashidah Pg Hj Ismail DSN; Chaiyasut C
    Biomed Pharmacother; 2020 Aug; 128():110310. PubMed ID: 32504921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Intestinal microflora, obesity and type 2 diabetes].
    Bondarenko VM; Maleev VV; Likhoded VG
    Zh Mikrobiol Epidemiol Immunobiol; 2014; (3):42-9. PubMed ID: 25286511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microbiome: The critters within.
    Gravitz L
    Nature; 2012 May; 485(7398):S12-3. PubMed ID: 22616099
    [No Abstract]   [Full Text] [Related]  

  • 9. [Analysis of prophylactic and therapeutic effect of probiotic preparations from position of new scientific technologies].
    Bondarenko VM; Rybalchenko OV
    Zh Mikrobiol Epidemiol Immunobiol; 2015; (2):90-104. PubMed ID: 26016351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of probiotics on intestinal barrier function.
    Mennigen R; Bruewer M
    Ann N Y Acad Sci; 2009 May; 1165():183-9. PubMed ID: 19538305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Intestinal flora, responsible for our body weight and an inflammation].
    Golay A; Giusti V
    Rev Med Suisse; 2009 Mar; 5(196):659. PubMed ID: 19462607
    [No Abstract]   [Full Text] [Related]  

  • 12. [Metabolic syndrome and intestinal microflora: what overall?].
    Plotnikova EIu; Krasnov OA
    Eksp Klin Gastroenterol; 2014; (12):64-73. PubMed ID: 26058115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Probiotic-induced changes in the intestinal epithelium: implications in gastrointestinal disease.
    Ramakrishna BS
    Trop Gastroenterol; 2009; 30(2):76-85. PubMed ID: 19760989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in intestinal microflora in obesity: cause or consequence?
    Bäckhed F
    J Pediatr Gastroenterol Nutr; 2009 Apr; 48 Suppl 2():S56-7. PubMed ID: 19300127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Probiotics: intestinal gatekeeping, immunomodulation, and hepatic injury.
    Versalovic J
    Hepatology; 2007 Sep; 46(3):618-21. PubMed ID: 17879361
    [No Abstract]   [Full Text] [Related]  

  • 16. Guests in the gut.
    Diabetes Forecast; 2012 Nov; 65(11):78-9. PubMed ID: 23175947
    [No Abstract]   [Full Text] [Related]  

  • 17. Pancreatic islet inflammation in type 2 diabetes: from alpha and beta cell compensation to dysfunction.
    Ehses JA; Ellingsgaard H; Böni-Schnetzler M; Donath MY
    Arch Physiol Biochem; 2009 Oct; 115(4):240-7. PubMed ID: 19645635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of intestinal barrier properties by probiotics: role in reversing colitis.
    Resta-Lenert SC; Barrett KE
    Ann N Y Acad Sci; 2009 May; 1165():175-82. PubMed ID: 19538304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A case of an effective application of probiotics in the complex therapy of severe type 1 diabetes mellitus and intestinal disbacteriosis].
    Rozanova GN; Voevodin DA
    Klin Med (Mosk); 2008; 86(1):67-8. PubMed ID: 18326290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Use of enterosorbent in the treatment of intestinal dysbiosis].
    Shcherbakov PL
    Eksp Klin Gastroenterol; 2009; (3):88-92. PubMed ID: 19928005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.